Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 177 entries
View as:

Alvocidib Biomarker-driven Phase 2 AML Study

Phase: N/A Priority: Normal
NCT ID: NCT02520011 Org: User:
Start: 03/14/16 End: 02/12/20 Due: 02/12/21

Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol

Phase: N/A Priority: Normal
NCT ID: NCT00685425 Org: User:
Start: 10/31/02 End: 03/31/03 Due: 03/31/04

A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder.

Phase: N/A Priority: Normal
NCT ID: NCT06037668 Org: User:
Start: 09/08/23 End: 01/10/24 Due: 01/10/25

A Phase 1, Open-Label, Single-photon Emission Computed Tomography (SPECT) Study to Evaluate Serotonin and Dopamine Transporter Occupancy After Multiple Dose Administration of SEP-228432 to Achieve Steady State in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01531972 Org: User:
Start: 02/29/12 End: 05/31/12 Due: 05/31/13

Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD

Phase: N/A Priority: Normal
NCT ID: NCT00064402 Org: User:
Start: 04/30/02 End: 03/31/04 Due: 03/31/05

Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01378429 Org: User:
Start: 07/31/11 End: 11/30/11 Due: 11/30/12

Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00857220 Org: User:
Start: 05/31/09 End: 10/31/11 Due: 10/31/12

A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00549666 Org: User:
Start: 08/31/07 End: 12/31/07 Due: 12/31/08

Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00789698 Org: User:
Start: 12/31/08 End: 07/31/11 Due: 07/31/12

Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic

Phase: N/A Priority: Normal
NCT ID: NCT01091662 Org: User:
Start: 06/30/10 End: 11/30/12 Due: 11/30/13

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

Phase: N/A Priority: Normal
NCT ID: NCT01358357 Org: User:
Start: 06/30/11 End: 04/30/15 Due: 04/30/16

Dasotraline SEP360-105 Pediatric PK/PD Study

Phase: N/A Priority: Normal
NCT ID: NCT02195167 Org: User:
Start: 07/31/14 End: 03/31/15 Due: 03/31/16

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02542696 Org: User:
Start: 08/31/15 End: 11/08/22 Due: 11/08/23

Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)

Phase: N/A Priority: Normal
NCT ID: NCT02491073 Org: User:
Start: 09/30/15 End: 03/31/16 Due: 03/31/17

A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00088634 Org: User:
Start: 05/31/04 End: 12/31/04 Due: 12/31/05

Efficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPD

Phase: N/A Priority: Normal
NCT ID: NCT00571428 Org: User:
Start: 11/30/07 End: 03/31/08 Due: 03/31/09

Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00909779 Org: User:
Start: 06/30/09 End: 06/30/12 Due: 06/30/13

A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)

Phase: N/A Priority: Normal
NCT ID: NCT01654536 Org: User:
Start: 09/30/12 End: 07/31/13 Due: 07/31/14

A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT03627195 Org: User:
Start: 06/07/18 End: 03/29/19 Due: 03/29/20

A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02275481 Org: User:
Start: 11/30/14 End: 09/14/16 Due: 09/14/17

Adult Attention Deficit Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01692782 Org: User:
Start: 12/31/12 End: 12/31/13 Due: 12/31/14

A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02352558 Org: User:
Start: 05/31/15 End: 05/16/19 Due: 05/16/20

A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression

Phase: N/A Priority: Normal
NCT ID: NCT03543410 Org: User:
Start: 06/26/18 End: 04/23/20 Due: 04/23/21

Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00790023 Org: User:
Start: 11/30/08 End: 02/28/09 Due: 02/28/10

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Phase: N/A Priority: Normal
NCT ID: NCT00868959 Org: User:
Start: 04/30/09 End: 02/28/13 Due: 02/28/14